IPHA Annual Working Capital
$119.80 M
+$14.17 M+13.42%
31 December 2023
Summary:
As of January 23, 2025, IPHA annual working capital is $119.80 million, with the most recent change of +$14.17 million (+13.42%) on December 31, 2023. During the last 3 years, it has fallen by -$37.59 million (-23.88%). IPHA annual working capital is now -42.92% below its all-time high of $209.87 million, reached on December 31, 2015.IPHA Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IPHA Quarterly Working Capital
$78.65 M
-$41.15 M-34.35%
30 June 2024
Summary:
As of January 23, 2025, IPHA quarterly working capital is $78.65 million, with the most recent change of -$41.15 million (-34.35%) on June 30, 2024. Over the past year, it has dropped by -$37.41 million (-32.23%). IPHA quarterly working capital is now -70.37% below its all-time high of $265.39 million, reached on June 30, 2015.IPHA Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IPHA Working Capital Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +13.4% | -32.2% |
3 y3 years | -23.9% | -32.2% |
5 y5 years | -14.8% | -32.2% |
IPHA Working Capital High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +81.3% | -34.4% | +19.0% |
5 y | 5-year | -23.9% | +81.3% | -50.0% | +19.0% |
alltime | all time | -42.9% | +434.0% | -70.4% | +198.8% |
Innate Pharma SA Working Capital History
Date | Annual | Quarterly |
---|---|---|
June 2024 | - | $78.65 M(-34.4%) |
Dec 2023 | $119.80 M(+13.4%) | $119.80 M(+3.2%) |
June 2023 | - | $116.05 M(+9.9%) |
Dec 2022 | $105.62 M(+59.8%) | $105.62 M(+2.9%) |
June 2022 | - | $102.62 M(+55.3%) |
Dec 2021 | $66.09 M(-58.0%) | $66.09 M(-36.2%) |
June 2021 | - | $103.61 M(-34.2%) |
Dec 2020 | $157.39 M(+21.4%) | $157.39 M(+72.0%) |
June 2020 | - | $91.49 M(-29.5%) |
Dec 2019 | $129.70 M(-7.7%) | $129.70 M(-6.6%) |
June 2019 | - | $138.86 M(-1.2%) |
Dec 2018 | $140.59 M(+84.2%) | $140.59 M(+119.4%) |
June 2018 | - | $64.08 M(-16.0%) |
Dec 2017 | $76.32 M(-53.0%) | $76.32 M(-44.3%) |
June 2017 | - | $136.98 M(-15.7%) |
Dec 2016 | $162.42 M(-22.6%) | $162.42 M(+0.3%) |
June 2016 | - | $161.99 M(-22.8%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2015 | $209.87 M(+151.8%) | $209.87 M(-20.9%) |
June 2015 | - | $265.39 M(+218.4%) |
Dec 2014 | $83.34 M(+50.6%) | $83.34 M(-21.9%) |
June 2014 | - | $106.72 M(+92.9%) |
Dec 2013 | $55.33 M(+63.2%) | $55.33 M(+110.3%) |
June 2013 | - | $26.32 M(-22.4%) |
Dec 2012 | $33.90 M(-30.2%) | $33.90 M(-10.8%) |
June 2012 | - | $38.00 M(-21.7%) |
Dec 2011 | $48.55 M(+9.7%) | $48.55 M(+29.9%) |
June 2011 | - | $37.39 M(-15.6%) |
Dec 2010 | $44.27 M(-34.1%) | $44.27 M(-10.2%) |
June 2010 | - | $49.32 M(-26.6%) |
Dec 2009 | $67.21 M(+34.3%) | $67.21 M |
Dec 2008 | $50.05 M(-23.9%) | - |
Dec 2007 | $65.75 M(-8.1%) | - |
Dec 2006 | $71.55 M(+219.0%) | - |
Dec 2005 | $22.43 M | - |
FAQ
- What is Innate Pharma SA annual working capital?
- What is the all time high annual working capital for Innate Pharma SA?
- What is Innate Pharma SA annual working capital year-on-year change?
- What is Innate Pharma SA quarterly working capital?
- What is the all time high quarterly working capital for Innate Pharma SA?
- What is Innate Pharma SA quarterly working capital year-on-year change?
What is Innate Pharma SA annual working capital?
The current annual working capital of IPHA is $119.80 M
What is the all time high annual working capital for Innate Pharma SA?
Innate Pharma SA all-time high annual working capital is $209.87 M
What is Innate Pharma SA annual working capital year-on-year change?
Over the past year, IPHA annual working capital has changed by +$14.17 M (+13.42%)
What is Innate Pharma SA quarterly working capital?
The current quarterly working capital of IPHA is $78.65 M
What is the all time high quarterly working capital for Innate Pharma SA?
Innate Pharma SA all-time high quarterly working capital is $265.39 M
What is Innate Pharma SA quarterly working capital year-on-year change?
Over the past year, IPHA quarterly working capital has changed by -$37.41 M (-32.23%)